CPL-043

N/A

Report date: 2025/01/26 19:36:26

NME

Base Information

Drug NameCPL-043

Drug Alias NameFGF1/2/3 inhibitor (Celon Pharma)CPL-043

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionFibroblast growth factor receptor 3 antagonistsFibroblast growth factor receptor 2 antagonistsFibroblast growth factor receptor 1 antagonists

TargetsFibroblast growth factor receptor 1Fibroblast growth factor receptor 3Fibroblast growth factor receptor 2

Therapy Area/IndicationsLung NeoplasmsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryPoland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCelon Pharma SP

China Registration ClassN/A

Develop Information

Active CompaniesCelon Pharma SP

Inactive CompaniesN/A

Active IndicationsLung Neoplasms

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A